Drinking Extra Water for to Prevent or Decrease Headaches

March 18, 2021 updated by: ThinkWell

Drinking Extra Water To Prevent or Decrease Headaches - A Feasibility Online Randomized Controlled Trial With Adult Participants

The purpose of this study is to find out if drinking extra water helps people prevent or relieve headaches and hunger and, if so, what volume of water is most effective and when is it best to drink it?

Study Overview

Detailed Description

If participants decide to participate in this trial, they will be asked to drink a specific amount of water at particular times of the day for 14 days. A computer will decide by chance the amount of water they will be asked to drink each day of the trial and the times at which to drink this.

There are different amounts and different times that people will be asked to drink water, this is so that the investigators can find out if there is an optimal volume of water to drink, and a best time to drink water to reduce headaches or hunger. The least amount of water the computer could ask participants to drink is half a glass (that is 4oz or 120ml). The largest volume of water the computer could ask participants to drink would be eight glasses of water a day (a total of 64oz or 2L) spread across the day (that is not all at once). Once the computer has assigned participants to a particular volume and times to drink water, these will remain the same for every day throughout the study.

Participants will be asked to provide some brief information about themselves at the beginning of the study (for example, age, sex, height and whether you exercise, smoke or not). During the study they will be asked to weigh themselves and record this, Their dietary habits and the amount they drink will be kept on a private and confidential page on the study website. They will be asked to fill in [2] confidential short surveys about how they feel and their views, one at the start and one at the end of the study.

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Oxfordshire
      • Oxford, Oxfordshire, United Kingdom, OX4 4DN
        • ThinkWell

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria

  • Any adult (defined as someone aged 18 or above) for whom advice to drink extra water is not contraindicated.

Exclusion Criteria

General exclusions

  • < 18 years of age
  • No personal email address
  • Pregnancy
  • Ecstasy recreational drug use

Exclusions Health Conditions

  • Impaired renal function
  • Chronic bowel problems
  • Low sodium levels
  • Diabetes insipidus
  • Schizophrenia or history of psychosis
  • Anorexia or bulimia
  • Congestive heart failure
  • Current chemotherapy treatment

Exclusions Concurrent Medications

  • Taking regular non-steroidal anti-inflammatory drugs
  • Diuretics (e.g. thiazides, indapamide, loop diuretics), also called "water tablets"
  • Anti-depressants: Selective serotonin re-uptake inhibitors (SSRIs), Tricyclic and tetracyclic antidepressants (TCAs),monoamine oxidase inhibitor (MAOIs)
  • Anti-psychotics (e.g. haloperidol)
  • Anti-convulsants (e.g. sodium valproate, carbamazepine)
  • Cancer drugs (anti-neoplastic agents)

Implicit exclusions

  • People without internet access
  • People who cannot read
  • People without the ability to understand the website and informed consent documents

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Daily extra water intake 2L

Timing of daily extra water intake intervention-A: extra water intake: 8 8oz glasses of water a day (2L) - 2 first thing in the morning before breakfast, 2 before midday or midday meal, 2 before afternoon meal and 2 before evening meal.

Intervention-B: Drink extra water at anytime over 24 hours

Amount of extra daily water intake to consume
Intervention-A: Timing of daily extra water intake specified Intervention-B: at any time during 24 hour period
Experimental: Daily extra water intake 1L

Timing of daily extra water intake Intervention-A: 4 8oz glasses of water a day (1L) - 1 first thing in the morning before breakfast, 1 before midday or midday meal, 1 before afternoon meal and 1 before evening meal.

Intervention-B: Drink extra water at anytime over 24 hours

Amount of extra daily water intake to consume
Intervention-A: Timing of daily extra water intake specified Intervention-B: at any time during 24 hour period
Experimental: Daily extra water intake 500ml

Timing of daily extra water intake Intervention-A: 2 8oz glasses of water a day (500ml) - each half an hour before a meals

Intervention-B: Drink extra water at anytime over 24 hours

Amount of extra daily water intake to consume
Intervention-A: Timing of daily extra water intake specified Intervention-B: at any time during 24 hour period
Experimental: Daily extra water intake 120ml

Timing of daily extra water intake Intervention-A: 1/2 a glass of water on waking (120ml). If you forget to drink your water first thing, do not drink it later in the day, just skip this day and drink ½ a glass the next day on waking.

Intervention-B: Drink extra water at anytime over 24 hours

Amount of extra daily water intake to consume
Intervention-A: Timing of daily extra water intake specified Intervention-B: at any time during 24 hour period

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reduction of headache frequency/intensity
Time Frame: Daily for 14 days
Online participant reported visual analog scales
Daily for 14 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hunger
Time Frame: Daily for 14 days
Online participant reported Visual analog scales
Daily for 14 days
Mood Questionnaire
Time Frame: Daily for 14 days
Mood will be measured online using happy, sad, neutral faces
Daily for 14 days
Body mass index (BMI)
Time Frame: Baseline and day 14
Participants will use an automated online BMI calculator
Baseline and day 14
Wellbeing
Time Frame: Baseline and day 14
Patient Reported Outcome Measurement Information System (PROMIS) will be used to measure patient-reported outcome (PRO) for answers that patients provide to questions to produce numeric values which indicate patients' state of wellbeing or suffering as well as their ability or lack of ability to function.
Baseline and day 14

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Amy I Price, PhD, University of Oxford

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

February 1, 2019

Primary Completion (Anticipated)

August 1, 2019

Study Completion (Anticipated)

November 1, 2019

Study Registration Dates

First Submitted

December 30, 2014

First Submitted That Met QC Criteria

January 2, 2015

First Posted (Estimate)

January 5, 2015

Study Record Updates

Last Update Posted (Actual)

March 23, 2021

Last Update Submitted That Met QC Criteria

March 18, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ThinkWell-PLOT-01

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Headache

Clinical Trials on Daily extra water intake

3
Subscribe